Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $226M | $281M | $345M | $472M |
| Revenue growth | — | 24.0% | 23.0% | 36.6% |
| Gross profit | $80.9M | $106M | $132M | $190M |
| Gross margin | 35.8% | 37.6% | 38.3% | 40.3% |
| Operating income | $20.4M | $48.5M | $63.6M | $72.9M |
| Operating margin | 9.0% | 17.3% | 18.4% | 15.5% |
| Net income | -$14.1M | $4.36M | $12.7M | $17.4M |
| Net margin | -6.2% | 1.6% | 3.7% | 3.7% |
| EPS (diluted) | -$0.09 | $0.03 | $0.08 | $0.13 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$5.89M | $20.3M | $26.6M | -$22.1M |
| Capital expenditures | $21.3M | $16.8M | $15.3M | $20.3M |
| Free cash flow | -$27.2M | $3.55M | $11.4M | -$42.5M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | — | $5.45M | $11.5M | $34.0M |
| Total assets | — | $711M | $774M | $1.10B |
| Total liabilities | — | $528M | $578M | $721M |
| Shareholders' equity | $178M | $182M | $196M | $383M |
| Retained earnings | — | — | -$8.34M | $9.03M |
| Shares (wtd avg diluted) | 159M | 167M | 167M | 132M |
Every figure is extracted from Karman Holdings Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.